Dr. Frederick R Aronson MD
Hematologist-Oncologist | Hematology & Oncology
100 Campus Dr Suite 108 Scarborough ME, 04074Rating
5/5
About
Dr. Frederick Aronson is a hematologist oncologist practicing in Scarborough, ME. Dr. Aronson specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Yale Univ Sch of Med, New Haven Ct 1980
Yale School of Medicine 1980
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- The secondary response of chickens given a primary inoculation of bovine serum albumin at different ages.
- Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas.
- Gossypol effects on endothelial cells and tumor blood flow.
- Pathogenesis of pulmonary edema during interleukin-2 therapy: correlation of chest radiographic and clinical findings in 54 patients.
- IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells.
- Life-threatening bullous skin eruptions during interleukin-2 therapy.
- High-dose recombinant interleukin-2 alone: a regimen with limited activity in the treatment of advanced renal cell carcinoma.
- Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effects.
- Activated endothelial cells resist lymphokine-activated killer cell-mediated injury. Possible role of induced cytokines in limiting capillary leak during IL-2 therapy.
- Ibrutinib increased survival more than chlorambucil in older patients with untreated chronic lymphocytic leukemia.
- Toxicity of immunotherapy with interleukin-2 and lymphokine-activated killer cells.
- Nephrectomy for metastatic renal cell carcinoma: a component of systemic treatment regimens.
- Summary statistics and treatment decisions.
Treatments
- Pancreatic Cancer
- Prostate Cancer
- Melanoma
- Skin Cancer
- Bladder Cancer
- Kidney Cancer
- Lung Cancer
- Esophageal Cancer
- Acute Myeloid Leukemia (aml)
- Lymphoma
- Thyroid Cancer
- Leukemia
- Testicular Cancer
- Extra Corporeal Shockwave Therapy
Dr. Frederick R Aronson MD's Practice location
Practice At 100 Campus Dr Suite 108
100 Campus Dr Suite 108 -Scarborough, ME 04074Get Direction
Dr. Frederick R Aronson MD's reviews
Write ReviewPatient Experience with Dr. Aronson
- Elizabeth b.
melanoma experience.
- E. b.
excellent experience.
Recommended Articles
![]()
How Immunotherapy Makes a Real Difference in Relapsed Hodgkin LymphomaHodgkin lymphoma, which affects about 0.2% of the people in the United States, is often treated using a combination of chemotherapy, radiation therapy, and stem cell transplant. Sometimes these treatments fail to halt the progress of the disease, and in other cases the cancer seems to halt but then...
![]()
The Lymphoma Research Foundation's Light it Red for Lymphoma NightLymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...
![]()
Stem Cell Therapy Puts 4-year-old's Ultra Rare Lymphoma in Remission4-year-old Jovon Moss was diagnosed with X-linked Lymphoproliferative Syndrome, a rare disorder of the immune system that led him to being taken back and forth to the hospital since his 3rd birthday.Jovon’s journey began in September of last year, when his mother, Brittany Fluellen, first began to...
![]()
Breaking News on the Treatment of Follicular LymphomaReuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...
![]()
Survey Shows Lack of Blood Cancer Knowledge Among AmericansIf anyone is asked to describe what cancer is, chances are they’ll be able to provide at least a rough definition of the disease. Generally speaking, cancer is the name for the rapid and uncontrollable development of cells in a certain part of the body. In addition to holding a general awareness...
![]()
Morphos Declared a "Breakthrough Therapy" for LymphomaMorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...
Nearby Providers
![]()
Dr. Christian Anton Thomas MD100 CAMPUS DRIVE SCARBOROUGH ME 04074![]()
Dr. Owen B Pickus D.O.2 Chabot St Westbrook ME 04092![]()
Dr. Devon L Evans MD100 Campus Dr Scarborough ME 04074![]()
Dr. Preston H Dalglish MD26 W Cole Rd Biddeford ME 04005![]()
Dr. Jingjing Hu MD22 Bramhall St Portland ME 04102![]()
Dr. Chiara Battelli MD100 CAMPUS DR UNIT 108 SCARBOROUGH ME 04074
Nearest Hospitals
MAINE MEDICAL CENTERl
22 BRAMHALL ST PORTLAND ME 4102MERCY HOSPITALl
144 STATE STREET PORTLAND ME 4101SOUTHERN MAINE HEALTH CAREl
1 MEDICAL CENTER DRIVE BIDDEFORD ME 4005